title: Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.
abstract: Hepatocyte growth factor, also known as scatter factor, is a pleiotropic cytokine, which stimulates cell motility, invasion, proliferation, survival and morphogenesis, and induces the expression of specific genes by activating its receptor tyrosine kinase. In this work we have isolated, characterized and used as agonists two monoclonal antibodies (mAbs) directed against the extracellular domain of HGF receptor to investigate the requirements for receptor activation and for the different biological responses. The two mAbs display similar affinities, react with epitopes different from the hepatocyte growth factor binding site, and behave as either full or partial agonists. The full agonist mAb (DO-24) triggers all the biological effects elicited by hepatocyte growth factor, namely motility, proliferation, cell survival, invasion, tubulogenesis and angiogenesis. The partial agonist mAb (DN-30) induces only motility. Only the full agonist mAb is able to induce and sustain the expression of urokinase-type plasminogen activator receptor for prolonged periods of time, while both mAbs up-regulate the constitutive expression of urokinase-type plasminogen activator. Both mAbs activate receptor phosphorylation, which, being strictly dependent on mAb bivalence, requires receptor dimerization. Since simple receptor dimerization is not sufficient to trigger full biological responses, we propose that the region on the ss chain of the receptor recognized by the full agonist mAb is crucial for optimal receptor activation.
authors.affiliation: Institute for Cancer Research (IRCC), University of Torino, Medical School, Candiolo, Italy. mprat@hal.ircc.polito.it
authors.forename: M
authors.initials: M
authors.lastname: Prat
authors.forename: T
authors.initials: T
authors.lastname: Crepaldi
authors.forename: S
authors.initials: S
authors.lastname: Pennacchietti
authors.forename: F
authors.initials: F
authors.lastname: Bussolino
authors.forename: P M
authors.initials: PM
authors.lastname: Comoglio
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D001665:Binding Sites; D002460:Cell Line; D002465:Cell Movement; D018985:Epitopes, B-Lymphocyte / Q000276:immunology; D017228:Hepatocyte Growth Factor / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D051379:Mice; D008807:Mice, Inbred BALB C; D010766:Phosphorylation; D019859:Proto-Oncogene Proteins c-met / Q000276:immunology / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000096:biosynthesis; D055293:Receptors, Urokinase Plasminogen Activator; D014443:Tyrosine / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D018985:Epitopes, B-Lymphocyte; D008024:Ligands; C524898:PLAUR protein, human; C524899:Plaur protein, mouse; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D014443:Tyrosine; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met